XENETIC - Trademark Details
Status: 700 - Registered
Serial Number
86569973
Registration Number
5926775
Word Mark
XENETIC
Status
700 - Registered
Status Date
2019-12-03
Filing Date
2015-03-19
Registration Number
5926775
Registration Date
2019-12-03
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2016-09-06
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
ZAK, HENRY S
Statements
Goods and Services
Chemical products used in industry and science for the development of and use in therapeutics for the treatment of disease such as blood disorders, neurological disorders, diabetes, and cancer, namely, polysialic acid, proteins, peptides, small molecules, liposomes, niosomes, viruses or histones; chemicals used in the preparation of pharmaceutical and therapeutic preparations for the development of and use in therapeutics for the treatment of disease such as blood disorders, neurological disorders, diabetes, and cancer, namely, polysialic acid, proteins, peptides, small molecules, liposomes, niosomes, viruses or histones; chemicals used in the preparation of vaccines and drug delivery systems for the development of and use in therapeutics for the treatment of disease such as blood disorders, neurological disorders, diabetes, and cancer, namely, polysialic acid, proteins, peptides, small molecules, liposomes, niosomes, viruses or histones; chemicals used in the preparation of liposomal drug delivery and polymer-based drug delivery systems for the development of and use in therapeutics for the treatment of disease such as blood disorders, neurological disorders, diabetes, and cancer; chemical additives used in manufacturing pharmaceutical and therapeutic preparations in connection with the treatment of blood disorders, neurological disorders, diabetes, and cancer, namely, polysialic acid, proteins, peptides, small molecules, liposomes, niosomes, viruses or histones; chemicals added to vaccines and drug delivery systems in connection with the treatment of blood disorders, neurological disorders, diabetes, and cancer to prevent vaccines from losing potency over time, namely, polysialic acid, proteins, peptides, small molecules, liposomes, niosomes, viruses or histones; chemical preparations used in manufacturing liposomal drug delivery and polymer-based drug delivery systems used for the development of and use in therapeutics for the treatment of disease such as blood disorders, neurological disorders, diabetes, and cancer, namely, polysialic acid, proteins, peptides, small molecules, liposomes, niosomes, viruses or histones; preservatives for prolonging the active life of pharmaceutical preparations and protecting them against degradation after administration into the body
Goods and Services
Pharmaceutical and therapeutic preparations for the development of and use in therapeutics for the treatment of disease such as cancer
Goods and Services
Medical and scientific research; discovery, development and design of pharmaceutical and therapeutic preparations; research, development and provision of scientific research information relating to drug delivery systems, vaccines, genetic vaccines and preparations for prolonging the active life of therapeutic preparations
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-03-30
Primary Code
005
First Use Anywhere Date
2017-05-00
First Use In Commerce Date
2017-05-00
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2015-03-30
Primary Code
042
First Use Anywhere Date
2014-05-00
First Use In Commerce Date
2014-05-00
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (LIMITED COMPANY (LTD.)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (LIMITED COMPANY (LTD.)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (LIMITED COMPANY (LTD.)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (LIMITED COMPANY (LTD.)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Jeromye V. Sartain
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2015-03-23 | NEW APPLICATION ENTERED IN TRAM |
| 2015-03-30 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2015-06-23 | ASSIGNED TO EXAMINER |
| 2015-06-29 | NON-FINAL ACTION WRITTEN |
| 2015-06-29 | NON-FINAL ACTION E-MAILED |
| 2015-06-29 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2015-12-29 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2016-01-14 | ASSIGNED TO LIE |
| 2016-01-14 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2016-01-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2016-02-04 | NON-FINAL ACTION WRITTEN |
| 2016-02-04 | NON-FINAL ACTION E-MAILED |
| 2016-02-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2016-07-29 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2016-07-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2016-07-29 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2016-07-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2016-08-02 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2016-08-17 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2016-09-06 | PUBLISHED FOR OPPOSITION |
| 2016-09-06 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2016-11-01 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2017-02-16 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2017-05-01 | TEAS EXTENSION RECEIVED |
| 2017-05-01 | EXTENSION 1 FILED |
| 2017-05-01 | EXTENSION 1 GRANTED |
| 2017-05-03 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2017-08-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2017-10-20 | TEAS EXTENSION RECEIVED |
| 2017-10-20 | EXTENSION 2 FILED |
| 2017-10-20 | EXTENSION 2 GRANTED |
| 2017-10-24 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2018-04-25 | TEAS EXTENSION RECEIVED |
| 2018-04-25 | EXTENSION 3 FILED |
| 2018-04-25 | EXTENSION 3 GRANTED |
| 2018-04-27 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2018-11-01 | TEAS EXTENSION RECEIVED |
| 2018-11-01 | EXTENSION 4 FILED |
| 2018-11-01 | EXTENSION 4 GRANTED |
| 2018-11-03 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-05-01 | TEAS EXTENSION RECEIVED |
| 2019-05-06 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2019-05-01 | EXTENSION 5 FILED |
| 2019-05-06 | EXTENSION 5 GRANTED |
| 2019-05-07 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-10-10 | TEAS STATEMENT OF USE RECEIVED |
| 2019-10-10 | USE AMENDMENT FILED |
| 2019-10-17 | STATEMENT OF USE PROCESSING COMPLETE |
| 2019-10-25 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 2019-10-26 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 2019-12-03 | REGISTERED-PRINCIPAL REGISTER |
